REBEKAH TIDWELL: Open Payments
NPI 1194476218 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$292 in 12 payments from 6 companies in 2025. Trend: 2023 $1,027 · 2024 $740 · 2025 $292
Food & beverage: $292
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $111 |
| ABBVIE INC. | 3 | $74 |
| Novo Nordisk Inc | 1 | $34 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $25 |
| Braeburn Inc. | 1 | $23 |
Products named: CAPLYTA, VRAYLAR, NEFFY, BRIXADI, QULIPTA, MAVYRET.
Industry payments across KY — which companies pay providers there.
